When BiOxyDyn, (www.bioxydyn.com), a spin out company from Manchester University, needed to turn their innovative research and Intellectual Property (IP) in non-invasive medical imaging into a commercially robust, well-architected and fully-documented set of software tools, they called on Tessella’s unique blend of expertise in image analysis and scientific software engineering. The collaboration has enabled BiOxyDyn [...]

Tessella are proud sponsors of the GDDIS Summit 2011 taking place on November 7th – 8th at the prestigious Waldorf Astoria in Orlando, Florida, US. Meet Dr Andrew Chadwick, Principal Consultant for Life Sciences at Tessella and Grant Stephen, CEO of Tessella Inc at stand number 12. If you would like a prearranged meeting please email [...]

Focus group and survey confirm growing complexity of drug development and increasing adoption of smarter clinical trials Tom Parke, Head of Clinical Technologies, Tessella I was lucky enough to join a focus group at the recent 8th Annual SAS Health Care & Life Sciences Executive Conference (http://www.sas.com/news/preleases/hlsconf-clinicaltrials.html). The group comprising of selected pharmaceutical industry executives, [...]

Tessella is a gold sponsor of the 2012 Bio-IT World Conference taking place at the World Trade Centre in Boston on the 24th and 26th of April 2012. If you would like to have a prearranged meeting with Tessella at the event then please email info@tessella.com. To find out more about Bio-IT World Conference 2012, visit [...]

As pharma R&D leaders bring together their discovery and early development organizations they face tough decisions. How do you optimize project planning across a seamless R&D process? What is the right balance between risk, cost and value in the face of uncertainty? When and how should you deploy predictive technologies such as biomarkers? This webinar [...]

By Andrew T. Chadwick and Matthew D. Segall Better individual and team decision-making should enhance R&D performance. Reproducible biases affecting human decision-making, known as cognitive biases, are well understood by psychologists.  These threaten objectivity and balance and so are credible causes for continuing unpleasant surprises in Development and high operating costs…read more

In Feb 2010 the FDA issued a draft guidance for industry on “Adaptive Design Clinical Trials for Drugs and Biologics” (pdf). Join Tom Parke in this on-demand webinar as he quizzes adaptive trial gurus Prof Don Berry and Dr Scott Berry on the implications of the FDA Guidance. Tom will be getting answers to the key [...]

Register for our live webcast on Tuesday, 8 June 2010 08:00 (PDT) 11:00 (EDT) 16:00 (BST)  17:00 (CEST) Join Tom Parke as he quizzes adaptive trial gurus Prof. Don Berry and Dr. Scott Berry on the implications of the recent FDA Guidance on Adaptive Design for Clinical Trials. Tom will be getting answers to the key [...]

Once again, Tessella is proudly sponsoring this years’ Bio-IT Best Practice Awards 2010, being held at the World Trade Centre, Boston, MA, USA on April 21, 2010 in conjunction with Bio-IT’s World Conference and Expo 2010. Established in 2003, the award programme recognizes teams in industry and academia for their outstanding innovations and excellence in the [...]

Faced with the challenge of falling success rates in drug development, clinical development teams must find new ways forward. Tessella and Berry Consultants believe that designing smarter clinical trials is part of the solution. We believe that better trial design can help: • Maximize the impact of your clinical trials on your drug development process. [...]